The healthy participant effect: insights and results from a population-based case–control study on breast cancer - Scorecard - MDSpire

The healthy participant effect: insights and results from a population-based case–control study on breast cancer

  • By

  • Kevin Maldonado-Cañón

  • Annika Möhl

  • Nadia Obi

  • Sabine Behrens

  • Fabian Flaßkamp

  • Petra Seibold

  • Jenny Chang-Claude

  • Heiko Becher

  • June 24, 2024

  • 0 min

Share

Clinical Scorecard: Examining the Healthy Participant Bias: Findings from a Population-Based Case-Control Study on Breast Cancer

At a Glance

CategoryDetail
ConditionBreast cancer
Key MechanismsHealthy participant bias due to differential response rates in cases and controls affecting mortality comparisons
Target PopulationPostmenopausal women diagnosed with breast cancer and matched controls from the general population
Care SettingPopulation-based epidemiologic case-control study

Key Highlights

  • Participation rates were 64.1% for breast cancer cases and 43.4% for controls, indicating potential healthy participant bias.
  • Standardized mortality ratios (SMRs) showed controls had 34% lower overall mortality than the reference population, indicating a healthy volunteer effect.
  • Similar healthy participant effects were observed in both cases and controls, suggesting limited bias impact on odds ratio estimates in this study.

Guideline-Based Recommendations

Diagnosis

  • Use histologically confirmed diagnosis for breast cancer cases in population-based studies.

Management

  • Recruit cases and controls from the same underlying population and match by sex and age to reduce selection bias.

Monitoring & Follow-up

  • Perform mortality follow-up and calculate standardized mortality ratios (SMRs) to assess healthy participant bias.
  • Stratify SMR analyses by age, calendar period, education, and cause of death to evaluate differential bias.

Risks

  • Low participation rates among controls can lead to healthy participant bias, potentially distorting study results.
  • Adjustment for social class or education may only partially correct for bias if health-conscious individuals are overrepresented.

Patient & Prescribing Data

Postmenopausal women with breast cancer and matched controls from general population

Not applicable; study focused on epidemiologic bias rather than treatment outcomes.

Clinical Best Practices

  • Ensure recruitment strategies maximize participation rates in both cases and controls to minimize healthy participant bias.
  • Use standardized mortality ratios to quantify and assess the extent of healthy volunteer effect in epidemiologic studies.
  • Consider education and social class as potential confounders and adjust analyses accordingly.
  • Interpret odds ratio estimates cautiously in case-control studies with low control participation rates.

References

Original Source(s)

Related Content